Successful Management of Rocuronium Induced Shock in Combination with Sugammadex and Traditional Therapy

Hyun Ho Seong, Nam Yung Kim, Yun Ho Yang, Ju Youn Kim, Seongsik Kang


Anaphylactic reactions during anesthesia can have a high mortality. The most common cause of anaphylaxis during anesthesia is neuromuscular blocking agents and, even though considered intermediate risk, rocuronium is frequently involved, probably due to its greater use. We present the case of a woman with anaphylactic shock secondary to the intravenous administration of rocuronium and recovered without complications by early aggressive management combination with conventional methods and sugammadex.


Anaphylaxis; Anesthesia; Rocuronium; Sugammadex

Full Text:



McDonnell NJ, Pavy TJ, Green LK et al. – Sugammadex in the management of rocuronium-induced anaphylaxis. Br J Anaesth, 2011;106:199-201.

Jones PM, Turkstra TP – Mitigation of rocuronium-induced anaphylaxis by sugammadex: the great unknown. Anaesthesia, 2010;65:89-90

Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999–2000. Anesthesiology 2003; 99: 536–45

Jakubowski MS, Barnard DE. Anaphylactic shock during operation for hydatid disease. Anesthesiology 1971; 34: 197–9.

CurrieM, Kerridge RK, BaconAK,Williamson JA. Crisis management during anaesthesia: anaphylaxis and allergy. Qual Saf Health Care 2005; 14: e19.

Mali S, Jambure R. Anaphyllaxis management: Current concepts. Anesth Essays Res. 2012 Jul-Dec;6(2):115-23. doi: 10.4103/0259-1162.108284. Review.

B. Plaud A new option for the treatment of anaphylaxis linked to steroidal neuromuscular blockers: How much should we grant to case reports? Can J Anaesth, 61 (2014), pp. 511-518

Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg 2007; 104: 575–81



  • There are currently no refbacks.

Copyright (c) 2018 Asian Journal of Pharmacy, Nursing and Medical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.